Dec22020

Publication: Incentives conditioned on tenofovir levels to support PrEP adherence among young South African women: a randomized trial

The following article was originally published in the Journal of the International AIDS Society on 28 November 2020. DTHF researchers Katherine Gill and Linda-Gail Bekker are co-authors. The full article can be accessed using the link below.   HIV incidence remains high among African adolescent girls and young women (AGYW), who would benefit from pre‐exposure…

Details

Battles won – and lost – against AIDS hold valuable lessons for managing COVID-19

Battles won – and lost – against AIDS hold valuable lessons for managing COVID-19 Sonali Pal Chaudhury/NurPhoto via Getty Images Linda-Gail Bekker, University of Cape Town World AIDS Day this year finds us still deep amid another pandemic – COVID-19. The highly infectious novel coronavirus has swept across the world, devastating health systems and laying…

Details
Nov102020

DTHC/F CELEBRATES NEWS THAT LONG-ACTING INJECTABLE PrEP IS SAFE AND EFFECTIVE IN PREVENTING HIV INFECTION IN AFRICAN WOMEN

10 November 2020 – The Desmond Tutu HIV Centre and Health Foundation welcome the announcement that another trial of long-acting injectable antiretroviral cabotegravir has demonstrated safety and efficacy in the prevention of HIV in cisgender women in Africa. Study sponsors ViiV, NIAID and the HPTN  announced yesterday that the randomised part of the landmark trial…

Details
Nov102020

SA’s latest COVID-19 vaccine trial crucial for future access

*The following press release was published by African Alliance on Monday 09 November 2020.   South Africa’s newest COVID-19 vaccine trial is another crucial step in ensuring a future vaccine works for South Africans and should be commended, says advocacy group the African Alliance and partner, the Vaccine Advocacy Resource Group. “Historically, Africa has had…

Details

South African scientists launch trial to test whether MMR vaccine protects front-line health-care workers against COVID-19

Vaccine may strengthen immune response to viral infections, including SARS CoV2   South African scientists from the Universities of the Witwatersrand and Cape Town are launching a clinical trial to test whether the childhood vaccine for measles, mumps and rubella (MMR) can protect front-line health-care workers from COVID-19, or reduce the severity of illness for…

Details
Sep302020

DTHF Mourns the Loss of ‘Berlin Patient’ Timothy Ray Brown

30 September 2020 – The Desmond Tutu Health foundation bids a sad farewell to Timothy Ray Brown today, who was the first person to be cured of HIV. Brown was declared ‘cured’ in 2008 following a complicated stem cell transplant for lymphoma. He became known as the “Berlin Patient” based on the city in which…

Details
Jul142020

2020 Adolescent Youth Health Policy Online Short Course

We are excited to announce we are running the 2020 Adolescent Youth Health Policy Online Short Course The course will start on 03 August 2020, Application deadline: 27 July 2020 Applications are now open! View the flyer here! Developed to support staff or governmental & non-governmental organisations working at a national, provincial & district levels, in the implementation…

Details
Jul102020

A LOOK BACK AT AN EXCITING WEEK AT AIDS 2020: VIRTUAL

The 23rd International AIDS conference took place entirely online this week, for the first time in the conference’s history. It brought together scientists, policymakers, healthcare professionals and activists in over 600 virtual sessions. Important HIV prevention, treatment and cure research was unveiled while a closer look was given to the impact of the COVID-19 pandemic…

Details